Peer-reviewedCC BY-NC-NDHemaSphere1 Oct 2026

Prognostic value of simultaneous [18F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T

Bastien Jamet¹
Huajun Sun¹
Chloé François¹
Hatem Necib¹
Aurélien Monnet¹
Éric Frampas²
Nicolas Blin³
Nicoletta Libera Lilli³
Caroline Bodet‐Milin¹
Philippe Moreau³
Françoise Kraeber‐Bodere¹
Cyrille Touzeau³

¹Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Médecine Nucléaire
²Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Radiologie
³Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, Hématologie

Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium
Aimaz Afrough, Oren Pasvolsky, Andrew J. Portuguese +52
Blood cancer journal1 Jul 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System Involvement
Misaki Uemura, Atsushi Marumo, Atsushi Obata +7
Internal Medicine15 Aug 2026Peer-reviewedCC BY-NC-NDFull text1 citedGeneral medicineJ-STAGE
Refractory Protein-losing Enteropathy Complicated by Cytomegalovirus Enterocolitis after Chemotherapy for Multiple Myeloma: A Fatal Adult Case
Mitsuaki Oura, Yuya Kurihara, Rio Motomura +7
Internal Medicine1 Sep 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthJ-STAGE
Prognostic Impact of EASIX According to the Timing of Assessment in Newly Diagnosed Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Diana Fortoeș, Ion Antohe, Vlad-Andrei Cianga +10
Medical sciences (Basel, Switzerland)1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy analysis and adverse event management of selinexor in the treatment of relapsed/refractory multiple myeloma.
Zengli Kuang, Yu Chen, Cuiai Ren
Frontiers in medicine6 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{jamet2026prognostic,
  title = {{Prognostic value of simultaneous [18F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T}},
  author = {Bastien Jamet and Huajun Sun and Chloé François and Hatem Necib and Aurélien Monnet and Éric Frampas and Nicolas Blin and Nicoletta Libera Lilli and Caroline Bodet‐Milin and Philippe Moreau and Françoise Kraeber‐Bodere and Cyrille Touzeau},
  journal = {HemaSphere},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13702043},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Prognostic value of simultaneous [18F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T
AU  - Bastien Jamet
AU  - Huajun Sun
AU  - Chloé François
AU  - Hatem Necib
AU  - Aurélien Monnet
AU  - Éric Frampas
AU  - Nicolas Blin
AU  - Nicoletta Libera Lilli
AU  - Caroline Bodet‐Milin
AU  - Philippe Moreau
AU  - Françoise Kraeber‐Bodere
AU  - Cyrille Touzeau
PY  - 2026
DA  - 2026/10/01
JO  - HemaSphere
UR  - https://europepmc.org/article/PMC/PMC13702043
SN  - 2572-9241
ER  -

Related

Cite